For: | Zeng M, Aguila FN, Patel T, Knapp M, Zhu XQ, Chen XL, Price PD. Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma. World J Gastrointest Oncol 2016; 8(5): 474-480 [PMID: 27190587 DOI: 10.4251/wjgo.v8.i5.474] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v8/i5/474.htm |
Number | Citing Articles |
1 |
Vivek Verma, Amy Moreno, Steven Lin. Advances in Radiotherapy Management of Esophageal Cancer. Journal of Clinical Medicine 2016; 5(10): 91 doi: 10.3390/jcm5100091
|
2 |
James W. Welsh, Steven N. Seyedin, Pamela K. Allen, Wayne L. Hofstetter, Jaffer A. Ajani, Joe Y. Chang, Daniel R. Gomez, Arya Amini, Stephen G. Swisher, Mariela A. Blum, Ahmed I. Younes, Quynh-Nhu Nguyen, Bruce D. Minsky, Jeremy J. Erasmus, Jeffrey H. Lee, Manoop Bhutani, Ritsuko U. Komaki. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. Journal of Thoracic Oncology 2017; 12(2): 375 doi: 10.1016/j.jtho.2016.10.013
|
3 |
Bao-tian Huang, Rui-hong Huang, Wu-zhe Zhang, Wen Lin, Long-jia Guo, Liang-yu Xu, Pei-xian Lin, Jian-zhou Chen, De-rui Li, Chuang-zhen Chen. Different definitions of esophagus influence esophageal toxicity prediction for esophageal cancer patients administered simultaneous integrated boost versus standard-dose radiation therapy. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00168-x
|
4 |
J. J. Tonison, S. G. Fischer, M. Viehrig, S. Welz, S. Boeke, K. Zwirner, B. Klumpp, L. H. Braun, D. Zips, C. Gani. Radiation Pneumonitis after Intensity-Modulated Radiotherapy for Esophageal Cancer: Institutional Data and a Systematic Review. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-38414-5
|
5 |
Hong-Mei Gao, Wen-Bin Shen, Jin-Rui Xu, You-Mei Li, Shu-Guang Li, Shu-Chai Zhu. Effect of SIB-IMRT-based selective dose escalation of local tumor on the prognosis of patients with esophageal cancer. International Journal of Clinical Oncology 2021; 26(9): 1640 doi: 10.1007/s10147-021-01943-7
|